SUCCESS OF CHIMERIC ANTI-GD2 ANTIBODY+GM-CSF+IL2 IMMUNOTHERAPY IN HIGH-RISK NEUROBLASTOMA (NB) IN FIRST RESPONSE: A CRITICAL APPRAISALWendy B. London,Paul Sondel,Andrew L. Gilman, Fevzi Ozkaynak,Susan Kreissman,Allen Buxton,Helen Chen,Katherine K. Matthay,Susan L. Cohn,John M. Maris,Alice L. YuPEDIATRIC BLOOD & CANCER(2009)引用 0|浏览0暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要